发明名称 MATRIX METALLOPROTEINASE PEPTIDES: ROLE IN DIAGNOSIS AND THERAPY
摘要 A family of metalloproteinases exist which cleave extracellular matrix molecules. These metalloproteinases are secreted in a latent inactive form and require activation in order to specifically cleave the preferred substrate. A series of peptides have been prepared based on the complete sequence analysis of type IV procollagenase. Peptide inhibitors were synthesized which correspond to cysteine repeat regions and histidine containing regions; the mechanism of action of these peptides involves inhibition of binding of the enzyme to the substrate. Peptide inhibitors were synthesized which correspond to the peptide cleaved off during activation, and constitute a novel class of metalproteinase inhibitors. These inhibitors are members of a series of peptides which contain the core amino acid sequence RKPRC or analogs thereof. The cysteine residue is required for activity. Affinity purified antibodies directed against specific peptides can be used to a) detect any general metalloproteinase enzyme with the sequence in part VAAHE or PRCGNPD, and distinguish it from other known members of the metalloproteinase family, b) block functional domains resulting in the inhibition of enzyme activity, and c) distinguish latent from activated forms of the enzyme.
申请公布号 WO9010228(A1) 申请公布日期 1990.09.07
申请号 WO1990US01060 申请日期 1990.03.01
申请人 THE UNITED STATES OF AMERICA, REPRESENTED BY THE S 发明人 LIOTTA, LANCE, A.;STETLER-STEVENSON, WILLIAM;KRUTZSH, HENRY
分类号 G01N33/53;A61K9/08;A61K38/55;A61P19/02;A61P35/00;A61P43/00;C07H21/04;C07K7/06;C07K7/08;C07K14/00;C07K14/81;C07K16/00;C07K16/38;C07K17/00;C12N5/10;C12N9/99;C12N15/09;G01N33/573 主分类号 G01N33/53
代理机构 代理人
主权项
地址